Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent)
Funding Amounts: $750,000 total ($250,000/year for 3 years, includes up to 10% indirect costs); 5–7 awards annually
Summary: Supports early-to-mid-career investigators pursuing bold, interdisciplinary research to transform understanding and treatment of neurodegenerative diseases.
Key Information: Forecasted cycle; eligibility limited to those within 1–8 years of independent research experience as of May 2026.